xenoport inc (XNPT:NASDAQ GS)
William J. Rieflin
Consultant and Director,Xenoport, Inc.
|Age||Total Calculated Compensation||This person is connected to 28 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Mr. William J. Rieflin, also known as Bill, has been the Chief Executive Officer of NGM Biopharmaceuticals, Inc. since October 5, 2010. Mr. Rieflin has been a Consultant of Xenoport, Inc., since September 17, 2010. He served as the President of Xenoport, Inc. since September 2004 and oversees its corporate development, human resources, legal and administrative functions. He served as Strategic Advisor at NGM Biopharmaceuticals, Inc. until October 5, 2010. He served as ...
3410 Central ExpresswayPhone: 408-616-7200
Santa Clara, California 95051
Board Members Memberships*
Consultant and Director
Chief Executive Officer and Director
Independent Lead Director, Chairman of Audit Committee and Member of Compensation Committee
The University of Chicago Booth School of Business
Stanford University Law school
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|Giovanni Caforio M.D.||Chief Executive Officer and Director|
Bristol-Myers Squibb Company
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Timothy J. Miller Ph.D.||Chief Executive Officer, President and Director|
Abeona Therapeutics Inc.
|Peter William Grant||Chief Executive Officer and Executive Director|
|567.0K GBP||Compensation as of Fiscal Year 2014.|